AzTrials
AzTrials

Automobile DrivingNCT06279520

Driving Ability Evaluation System to Improve the Conditional Driving License System: Safety and Feasibility Study.

A study testing VR Driving Simulator, Computerized Neurocognitive Function Test and Driver Test Station in people with Automobile Driving, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities in healthy adults. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Read more about this study

Who is it for?
Ages 19 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Automobile Driving
What is being tested?
VR Driving Simulator, Computerized Neurocognitive Function Test and Driver Test Station
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteSouth Korea
Study dates
19 Feb 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Individuals over the age of 19 who are currently driving.
  • Individuals capable of understanding and following the researcher's instructions.
  • Individuals who can understand the purpose of the research and have consented to participate

Who cannot join

  • Those who have not signed the consent form.
  • Individuals with a history of severe dizziness or epilepsy.
  • Patients with restrictions on sitting in a wheelchair or chair for more than 30 minutes.
  • Patients with severe shoulder pain.
  • Patients whose range of motion in major joints is restricted by more than 50%.
  • Pregnant women.
Show all 10Show fewer
  • Patients with pressure sores.
  • Patients with limitations on simulator use due to heterotopic ossification.
  • Patients with acute fractures.
  • Other patients for whom participation in the study is expected difficult.

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Seoul National University Hospital

    Seoul

    Ja-Ho Leigh, M.D. Msc., mazican@gmail.com

    Recruiting

Other trials in South Korea

About this study

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities in healthy adults.

This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function and cognitive function of healthy drivers. to identify the correlation between their outcomes and the VR driving simulator's result

Read the detailed description

VR driving simulator is to evaluate the driving abilities of high-risk drivers, including the elderly and those with medical conditions, potentially prone to incapacitate driving.

It aims to evaluate whether drivers who were anticipated to have impaired driving ability can handle highly risky situations for traffic accidents. The results of this study can be used to make the drivers know their status and encourage them to take safety training. Until now, the evaluation of driving abilities could only be conducted at licensing centers. However, the use of VR technology can eliminate spatial limitations, offering a promising tool for the objective assessment of driving skills.

Being tested
VR Driving Simulator, Computerized Neurocognitive Function Test, Driver Test Station, On-road field driving Test

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR Driving SimulatorDevice

    Evaluation of usual road driving abilities and assessment of response capabilities in accident-prone situations through a VR driving simulator

  • Computerized Neurocognitive Function TestOther

    Evaluation of cognitive levels including attention and memory (the Trail Making Test, Digit Span Test, Auditory (or Visual) Continuous Performance Test , and Card Sorting)

  • Driver Test StationOther

    Conducting qualified tests of a person's basic physical driving ability including steering, acceleration and braking, using Driver Test Station(Autoadapt AB, Stenkullen, Sweden)

  • On-road field driving TestOther

    Researchers and driver's license supervisors ride in the driver's license test vehicle to evaluate the subject's actual driving ability. the validity of the VR simulator by comparing the results of the VR simulator with the actual vehicle driving ability.

Study groups in NCT06279520
Study groupRoleWhat they receive
Adult driversOtherIndividuals over the age of 19 who are currently driving
Receives: Device: VR Driving Simulator; Other: Computerized Neurocognitive Function Test; Other: Driver Test Station; Other: On-road field driving Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of VR driving simulator

    A questionnaire evaluating symptoms of simulator sickness such as dizziness or nausea and comprehension of contents

    Measured: 2 hours

  2. Driving performance in simulator, measured by driving errors

    Driving performance in simulator will be measured by driving errors during VR simluation of driving. These errors will be evaluated based on the criteria used for driving license tests, including violations of traffic laws.

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2024
  2. Study start19 Feb 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06279520
Sponsor's protocol ID
2023-08-003
Status last verified
Feb 2024
First submitted
14 Feb 2024
Last updated
28 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR Driving Simulator, Computerized Neurocognitive Function Test and Driver Test Station in people with Automobile Driving, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ja-Ho Leigh (+82-31-580-5650, magican1@snu.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of VR driving simulator (time frame: 2 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in